{{Infobox disease
 | Name           = Substance-induced psychosis
 | Image          =
 | Caption        =
 | DiseasesDB     =
 | ICD10          = {{ICD10|F|10||f|10}}.5-{{ICD10|F|19||f|10}}.5
 | ICD9           = {{ICD9|292.1}}
 | ICDO           =
 | OMIM           =
 | MedlinePlus    =
 | eMedicineSubj  =
 | eMedicineTopic =
 | MeshID         = D011605
}}
'''Substance-induced psychosis''' is a form of [[substance-related disorder]] where [[psychosis]] can be attributed to substance use.

Various psychoactive substances (both legal and illegal) have been implicated in causing, exacerbating, and/or precipitating psychotic states and/or disorders in users.  This is also true of several medications that are not traditionally considered psychoactive drugs. Individuals who have a substance induced psychosis tend to have a greater awareness of their psychosis and tend to have higher levels of suicidal thinking compared to individuals who have a primary psychotic illness.<ref name="pmid21728034">{{cite journal |author=Grant KM, LeVan TD, Wells SM, ''et al.'' |title=Methamphetamine-associated psychosis |journal=J Neuroimmune Pharmacol |volume=7 |issue=1 |pages=113–39 |year=2012 |month=March |pmid=21728034 |pmc=3280383 |doi=10.1007/s11481-011-9288-1 |url=}}</ref>

==Substances==
Psychotic states may occur after ingesting a variety of substances both legal and illegal and both prescription and non-prescription.  Usually such states are temporary and not irreversible, with [[fluoroquinolone]]-induced psychosis being a notable exception.  Drugs whose use, abuse or withdrawal are implicated include the following:

===[[International Classification of Diseases|ICD]]-10===
* F10.5 alcohol:<ref name=alcohol>{{Cite web|url=http://www.emedicine.com/med/topic3113.htm |title=Alcohol-Related Psychosis |accessdate=September 27, 2006 |last=Larson |first=Michael |date=2006-03-30 |work=eMedicine |publisher=WebMD}}</ref><ref>{{Cite journal|last=Soyka |first=Michael |year=1990 |month=March |title=Psychopathological characteristics in alcohol hallucinosis and paranoid schizophrenia |journal=[[Acta Psychiatrica Scandinavica]] |volume=81 |issue=3 |pages=255–9 | pmid = 2343749 |doi=10.1111/j.1600-0447.1990.tb06491.x}}</ref><ref name=Gossman_2005>{{Cite web|url=http://www.emedicine.com/EMERG/topic123.htm |title=Delirium Tremens |accessdate=October 16, 2006 |last=Gossman |first=William |date=November 19, 2005 |work=eMedicine |publisher=WebMD}}</ref> Alcohol is a common risk of causing psychotic disorders or episodes, which may occur through acute intoxication, chronic alcoholism, withdrawal, exacerbation of existing disorders, or acute idiosyncratic reactions.<ref name="emedicine.medscape.com">http://emedicine.medscape.com/article/289848-overview Alcohol-Related Psychosis</ref>  Research has shown that alcohol abuse causes an 8-fold increased risk of psychotic disorders in men and a 3 fold increased risk of psychotic disorders in women.<ref name="Tien AY, Anthony JC 1990 473–80">{{Cite journal|author=Tien AY, Anthony JC |title=Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences |journal=J. Nerv. Ment. Dis. |volume=178 |issue=8 |pages=473–80 |year=1990 |month=August |pmid=2380692 |doi= 10.1097/00005053-199017880-00001|url=}}</ref><ref>{{Cite journal|author=Cargiulo T |title=Understanding the health impact of alcohol dependence |journal=Am J Health Syst Pharm |volume=64 |issue=5 Suppl 3 |pages=S5–11 |year=2007 |month=March |pmid=17322182 |doi=10.2146/ajhp060647 |url=}}</ref> While the vast majority of cases are acute and resolve fairly quickly upon treatment and/or abstinence, they can occasionally become chronic and persistent.<ref name="emedicine.medscape.com"/> Alcoholic psychosis is sometimes misdiagnosed as another mental illness such as [[schizophrenia]].<ref>{{Cite journal|author=Schuckit MA |title=Alcoholism and other psychiatric disorders |journal=Hosp Community Psychiatry |volume=34 |issue=11 |pages=1022–7 |year=1983 |month=November |pmid=6642446 |doi= |url=}}</ref>

* F12.5 cannabinoid: Some studies indicate that [[cannabis (drug)|cannabis]], especially certain strains containing large proportions of THC and low proportions of CBD,<ref>[http://www.nature.com/npp/journal/v35/n3/pdf/npp2009184a.pdf ''THC and Psychosis''] from ''Neuropsychopharmacology'' 35, 764–774, dated 1 February 2010.</ref> may lower the threshold for psychosis, and thus help to trigger full-blown psychosis in some people.<ref name = Deg>{{Cite journal|author=Degenhardt L |title=The link between cannabis use and psychosis: furthering the debate |journal=Psychological Medicine |volume=33 |issue=1 |pages=3–6 |year=2003 |month=January |pmid=12537030 |doi=10.1017/S0033291702007080}}</ref> Early studies have been criticized for failing to consider other drugs (such as [[LSD]]) that the participants may have used before or during the study, as well as other factors such as pre-existing ("comorbid") mental illness. However, more recent studies with better controls have still found an increase in risk for psychosis in cannabis users, albeit a more modest one.<ref>{{Cite journal|author=Moore TH, Zammit S, Lingford-Hughes A, ''et al.'' |title=Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review |journal=Lancet |volume=370 |issue=9584 |pages=319–28 |year=2007 |month=July |pmid=17662880 |doi=10.1016/S0140-6736(07)61162-3}}</ref>  It is still not clear whether this is a causal link, and it is possible that cannabis use only increases the chance of psychosis in people already predisposed to it; or that people with developing psychosis use [[cannabis]] to provide temporary relief of their mental discomfort. Cannabis use has increased dramatically over past few decades but declined in the last decade, whereas the rate of psychosis has not increased. This suggests that a direct causal link is unlikely for all users.<ref>{{Cite journal|author=Degenhardt L, Hall W, Lynskey M |title=Comorbidity between cannabis use and psychosis: Modelling some possible relationships.| version = Technical Report No. 121. |publisher=Sydney: National Drug and Alcohol Research Centre.|year=2001 |url=http://ndarc.med.unsw.edu.au/NDARCWeb.nsf/resources/TR_18/$file/TR.121.PDF|format=[[PDF]]|accessdate=2006-08-19 }}</ref>

* F13.5 sedatives/hypnotics ([[barbiturate]]s;<ref name=de_Paola_et_al_2004>{{Cite journal|author=de Paola L, Mäder MJ, Germiniani FM, ''et al.'' |title=Bizarre behavior during intracarotid sodium amytal testing (Wada test): are they predictable? |journal=Arquivos De Neuro-psiquiatria |volume=62 |issue=2B |pages=444–8 |year=2004 |month=June |pmid=15273841 |doi=10.1590/S0004-282X2004000300012}}</ref><ref name=Sarrecchia_et_al_1998>{{Cite journal|author=Sarrecchia C, Sordillo P, Conte G, Rocchi G |title=[Barbiturate withdrawal syndrome: a case associated with the abuse of a headache medication] |language=Italian |journal=Annali Italiani Di Medicina Interna |volume=13 |issue=4 |pages=237–9 |year=1998 |pmid=10349206}}</ref> [[benzodiazepine]]s<ref name=White_et_al_1982>{{Cite journal|author=White MC, Silverman JJ, Harbison JW |title=Psychosis associated with clonazepam therapy for blepharospasm |journal=The Journal of Nervous and Mental Disease |volume=170 |issue=2 |pages=117–9 |year=1982 |month=February |pmid=7057171 |doi=10.1097/00005053-198202000-00010}}</ref><ref name=Jaffe_et_al_1986>{{Cite journal|author=Jaffe R, Gibson E |title=Clonazepam withdrawal psychosis |journal=Journal of Clinical Psychopharmacology |volume=6 |issue=3 |pages=193 |year=1986 |month=June |pmid=3711371 |doi=10.1097/00004714-198606000-00021}}</ref><ref name=Hallberg_et_al_1964>{{Cite journal|author=Hallberg RJ, Lessler K, Kane FJ |title=Korsakoff-Like Psychosis Associated With Benzodiazepine Overdosage |journal=The American Journal of Psychiatry |volume=121 |issue= |pages=188–9 |year=1964 |month=August |pmid=14194223 |url=http://ajp.psychiatryonline.org/article.aspx?Volume=121&page=188&journalID=13}}</ref>): It is also important to this topic to understand the [[paradoxical effects]] of some sedative drugs.<ref>{{Cite journal|author=Hall RC, Zisook S |title=Paradoxical reactions to benzodiazepines |journal=British Journal of Clinical Pharmacology |volume=11 |issue= Suppl 1|pages=99S–104S |year=1981 |pmid=6133541 |pmc=1401636}}</ref> Serious complications can occur in conjunction with the use of sedatives creating the opposite effect as to that intended. [[Malcolm Lader]] at the [[Institute of Psychiatry]] in London estimates the incidence of these adverse reactions at about 5%, even in short-term use of the drugs.<ref>Lader M, Morton S. Benzodiazepine Problems. British Journal of Addiction 1991; 86: 823-828</ref> The [[paradoxical reactions]] may consist of [[clincal depression|depression]], with or without [[suicide|suicidal tendencies]], [[phobias]], aggressiveness, [[violence|violent behavior]] and symptoms sometimes misdiagnosed as ''psychosis''.<ref>[http://www.benzo.org.uk/paradox.htm  Benzodiazepines: Paradoxical Reactions & Long-Term Side-Effects]</ref><ref>Hansson O, Tonnby B. [Serious Psychological Symptoms Caused by Clonazepam.] Läkartidningen 1976; 73: 1210-1211.</ref> However, psychosis is more commonly related to the [[benzodiazepine withdrawal syndrome]].<ref>{{Cite journal|author=Pétursson H |title=The benzodiazepine withdrawal syndrome |journal=Addiction |volume=89 |issue=11 |pages=1455–9 |year=1994 |month=November |pmid=7841856 |doi=10.1111/j.1360-0443.1994.tb03743.x}}</ref>

* F14.5 cocaine<ref>{{Cite journal|last=Brady |first=K. T. |coauthors=R. B. Lydiard, R. Malcolm, and J. C. Ballenger |year=1991 |month=December |title=Cocaine-induced psychosis |journal=Journal of Clinical Psychiatry |volume=52 |issue=12 |pages=509–512 | pmid = 1752853}}</ref>

* F15.5 other stimulants: [[amphetamine]]s;<ref name="Diaz">Diaz, Jaime. How Drugs Influence Behavior. Englewood Cliffs: Prentice Hall, 1996.</ref> [[methamphetamine]];<ref name="Diaz" /> [[methylphenidate]].<ref name="Diaz" /> See also [[stimulant psychosis]].

* F16.5 hallucinogens ([[LSD]] and others)

The code F11.5 is reserved for opioid-induced psychosis, and F17.5 is reserved for tobacco-induced psychosis, but neither substance is traditionally associated with the induction of psychosis.

The code F15.5 also includes [[caffeine]]-induced psychosis, despite not being specifically listed in the [[DSM-IV]]. However, there is evidence that caffeine, in extreme acute doses or when severely abused for long periods of time, may induce psychosis.<ref name=caffeine_psychosis>{{Cite journal|author=Hedges DW, Woon FL, Hoopes SP |title=Caffeine-induced psychosis |journal=CNS Spectrums |volume=14 |issue=3 |pages=127–9 |year=2009 |month=March |pmid=19407709}}</ref><ref name=energy_psychosis>{{Cite journal|author=Cerimele JM, Stern AP, Jutras-Aswad D |title=Psychosis following excessive ingestion of energy drinks in a patient with schizophrenia |journal=The American Journal of Psychiatry |volume=167 |issue=3 |pages=353 |year=2010 |month=March |pmid=20194494 |doi=10.1176/appi.ajp.2009.09101456}}</ref>

===Other===
*[[Fluoroquinolone]] drugs, fluoroquinolone use has been linked to serious cases of toxic psychosis that have been reported to be irreversible and permanent, see [[Fluoroquinolone toxicity]] <ref name="pnawf">{{Cite journal| author =Cohen JS | year =2001 | month =December | title =Peripheral Neuropathy Associated with Fluoroquinolones | journal =Ann Pharmacother | volume =35 | issue =12 | pages =1540–7 | pmid =11793615 | url =http://fqvictims.org/fqvictims/News/neuropathy/Neuropathy.pdf | format =PDF | doi =10.1345/aph.1Z429 }}</ref><ref>{{Cite journal|author=Adams M, Tavakoli H |title=Gatifloxacin-induced hallucinations in a 19-year-old man |journal=Psychosomatics |volume=47 |issue=4 |pages=360 |year=2006 |pmid=16844899 |doi=10.1176/appi.psy.47.4.360 |url=http://psy.psychiatryonline.org/cgi/content/full/47/4/360}}</ref><ref>{{Cite journal|author=Mulhall JP, Bergmann LS |title=Ciprofloxacin-induced acute psychosis |journal=Urology |volume=46 |issue=1 |pages=102–3 |year=1995 |month=July |pmid=7604468 |doi=10.1016/S0090-4295(99)80171-X |url=http://linkinghub.elsevier.com/retrieve/pii/S0090-4295(99)80171-X}}</ref><ref>{{Cite journal|author=Reeves RR |title=Ciprofloxacin-induced psychosis |journal=Ann Pharmacother |volume=26 |issue=7–8 |pages=930–1 |year=1992 |pmid=1504404 |doi= |url=}}</ref><ref>{{Cite journal|author=Yasuda H, Yoshida A, Masuda Y, Fukayama M, Kita Y, Inamatsu T |title=[Levofloxacin-induced neurological adverse effects such as convulsion, involuntary movement (tremor, myoclonus and chorea like), visual hallucination in two elderly patients] |language=Japanese |journal=Nippon Ronen Igakkai Zasshi |volume=36 |issue=3 |pages=213–7 |year=1999 |month=March |pmid=10388331 |doi= 10.3143/geriatrics.36.213|url=}}</ref><ref>{{Cite journal|author=Azar S, Ramjiani A, Van Gerpen JA |title=Ciprofloxacin-induced chorea |journal=Mov. Disord. |volume=20 |issue=4 |pages=513–4; author reply 514 |year=2005 |month=April |pmid=15739219 |doi=10.1002/mds.20425}}</ref><ref>{{Cite journal|author=Kukushkin ML, Igonkina SI, Guskova TA |title=Mechanisms of pefloxacin-induced pain |journal=Bull. Exp. Biol. Med. |volume=137 |issue=4 |pages=336–8 |year=2004 |month=April |pmid=15452594 |doi= 10.1023/B:BEBM.0000035122.45148.93|url=}}</ref><ref>{{Cite journal|author=Christie MJ, Wong K, Ting RH, Tam PY, Sikaneta TG |title=Generalized seizure and toxic epidermal necrolysis following levofloxacin exposure |journal=Ann Pharmacother |volume=39 |issue=5 |pages=953–5 |year=2005 |month=May |pmid=15827068|doi=10.1345/aph.1E587|url=http://www.theannals.com/cgi/pmidlookup?view=long&pmid=15827068}}</ref> The related quinoline derivative [[mefloquine]] (Lariam) has also been associated with psychosis.<ref>{{Cite journal|author=Marsepoil T, Petithory J, Faucher JM, Ho P, Viriot E, Benaiche F |title=[Encephalopathy and memory disorders during treatments with mefloquine] |language=French |journal=Rev Med Interne |volume=14 |issue=8 |pages=788–91 |year=1993 |pmid=8191092 |doi= |url=}}</ref><ref>{{Cite journal|author=Phillips-Howard PA, ter Kuile FO |title=CNS adverse events associated with antimalarial agents. Fact or fiction? |journal=Drug Saf |volume=12 |issue=6 |pages=370–83 |year=1995 |month=June |pmid=8527012 |doi= 10.2165/00002018-199512060-00003|url=}}</ref>
*some [[over-the-counter drug]]s, including:
**[[Dextromethorphan]] (DXM) at high doses.<ref name=DXM>{{Cite journal|doi=10.1176/appi.ajp.157.2.304 |last = Price | first = L. H. |coauthors=Lebel, J. | year = 2000 | title = Dextromethorphan-Induced Psychosis | journal = American Journal of Psychiatry | volume = 157 | issue = 2 | pages = 304 | url = http://ajp.psychiatryonline.org/cgi/content/full/157/2/304 | pmid = 10671422 }}</ref><ref>{{ cite journal | url = http://www.primarypsychiatry.com/aspx/articledetail.aspx?articleid=953 | title = Deciphering a Psychosis: A Case of Dextromethorphan-Induced Symptoms | author = Lachover, L. | journal = Primary Psychiatry | year = 2007 | volume = 14 | issue = 1 | pages = 70-72 }}</ref>
**Certain [[antihistamine]]s at high doses.<ref name=diphenhydramine_trip_therapeutic>{{Cite journal | doi = 10.1016/S0735-6757(97)90212-6 | author = Sexton,  J. D.; Pronchik, D. J. | title = Diphenhydramine-induced psychosis with therapeutic doses | journal = The American Journal of Emergency Medicine | volume = 15 | issue = 5 | pages = 548–549 | year = 1997 | pmid = 9270406 }}</ref><ref name=diphenhydramine_trip_supratherapeutic>{{Cite journal | last = Lang | first = K. | coauthors = Sigusch, H.; Müller, S. | year = 1995 | trans_title = An anticholinergic syndrome with hallucinatory psychosis after diphenhydramine poisoning | language = German | journal = [[Deutsche Medizinische Wochenschrift]] | volume = 120 | issue = 49 | pages = 1695–1698 | pmid = 7497894 | doi = 10.1055/s-2008-1055530 }}</ref><ref name=diphenhydramine_poisoning_psychosis>{{Cite journal | last=Schreiber | first = W. | coauthors = Pauls, A. M.; Krieg, J. C. | year = 1988 | trans_title = Toxic psychosis as an acute manifestation of diphenhydramine poisoning | language = German | journal = [[Deutsche Medizinische Wochenschrift]] | volume = 113 | issue = 5 | pages = 180–183 | pmid = 3338401 | doi = 10.1055/s-2008-1067616 }}</ref><ref name=Promethazine>{{Cite journal | last = Timnak | first = C. | coauthors = Gleason, O. | year = 2004 | title = Promethazine-Induced Psychosis in a 16-Year-Old Girl | journal = Psychosomatics | volume = 45 | issue = 1 | pages = 89–90 | pmid = 14709767 | doi = 10.1176/appi.psy.45.1.89 }}</ref>
**Cold Medications<ref>{{ cite journal | url = http://pediatrics.aappublications.org/cgi/content/full/108/3/e52 | journal = Pediatrics | volume = 108 | issue = 3 | year = 2001 | page = e52 }}</ref> (i.e. containing [[Phenylpropanolamine]], or PPA)

*prescription drugs:
**[[Prednisone]] and other corticosteroids<ref>{{Cite pmid|438794}}</ref>
**[[Isotretinoin]]{{Citation needed|date=April 2010}}
**Anticholinergic drugs
***[[atropine]]<ref name=Bergman_et_al_1980>{{Cite journal | last = Bergman | first = K. R. | coauthors = Pearson, C.; Waltz, G. W.; Evans R. III | title = Atropine-induced psychosis. An unusual complication of therapy with inhaled atropine sulfate | journal = Chest | year = 1980 | volume = 78 | issue = 6 | pages = 891–893 | pmid = 7449475 | doi = 10.1378/chest.78.6.891 }}</ref><ref name=Varghese_et_al_1990>{{Cite journal | last = Varghese | first = S. | coauthors = Vettath, N.; Iyer, K.; Puliyel, J. M.; Puliyel, M. M. | title = Ocular atropine induced psychosis--is there a direct access route to the brain? | journal = Journal of the Association of Physicians of India | year = 1990 | volume = 38 | issue = 6 | pages = 444–445 | pmid = 2384469 }}</ref>
***[[scopolamine]]<ref name=Barak_and_Weiner_2006>{{Cite journal | last = Barak | first = Segev | coauthors = Weiner, I. | title = Scopolamine Induces Disruption of Latent Inhibition Which is Prevented by Antipsychotic Drugs and an Acetylcholinesterase Inhibitor | journal = Neuropsychopharmacology | year = 2006 | volume = 32 | issue = 5 | pages = 989–999 | doi = 10.1038/sj.npp.1301208 | pmid = 16971898 }}</ref>
**[[antidepressants]]{{Citation needed|date=April 2010}}
**[[L-dopa]]<ref>{{ cite journal | author = Carey, R. J.; Pinheiro-Carrera, M.; Dai, H.; Tomaz, C.; Huston, J. P. | title = l-DOPA and psychosis: Evidence for l-DOPA-induced increases in prefrontal cortex dopamine and in serum corticosterone | journal = Biological Psychiatry | year = 1995 | volume = 38 | issue = 10 | pages = 669-676 | doi = 10.1016/0006-3223(94)00378-5 | pmid = 8555378 }}</ref>
**[[antiepileptics]]<ref>{{ cite journal | author = Ettinger, A. B. | title = Psychotropic effects of antiepileptic drugs | journal = Neurology | year = 2006 | volume = 67 | issue = 11 | pages = 1916-1925 }}</ref>

*Other illegal drugs (not listed above), including:
**[[Methylenedioxymethamphetamine|MDMA]] (ecstasy)<ref>http://www.erowid.org/references/refs_view.php?A=ShowDoc1&ID=526 'Ecstasy' Psychosis and Flashbacks F.J. CREIGHTON,D. L. BLACK and C. E. HYDE</ref>
**[[Phencyclidine]] (PCP)<ref>http://www.minddisorders.com/Py-Z/Substance-induced-psychotic-disorder.html Substance-induced psychotic disorder</ref>
**[[Ketamine]]

*Synthetic [[research chemicals]] used recreationally, including:
**[[JWH-018]] and some other [[synthetic cannabinoids]], or mixtures containing them (e.g. "Spice", "Kronic", "MNG" or "Mr. Nice Guy", "Relaxinol", etc.).<ref>http://www.airforcetimes.com/news/2011/06/air-force-spice-users-risk-psychosis-says-doctor-061111w/ Spice users risk psychosis, doctor says By Gidget Fuentes - Staff writer
Accessed 06-25-2011</ref> Various "JWH-XXX" compounds in "Spice" or "Incense" <ref>http://en.wikipedia.org/wiki/Synthetic_cannabis</ref> have also been found.
**[[Mephedrone]] and related amphetamine-like drugs sold as "bath salts" or "plant food".<ref>http://www.addictions.com/bath-salt-addiction Bath Salt Addiction, Accessed 06-25-2011
</ref>

*Plants
**[[Hawaiian baby woodrose]] (contains [[ergine]])
**[[Morning glory]] seeds (contains [[ergine]])
**[[Jimson weed]]<ref name=Kurzbaum>{{Cite journal|last=Kurzbaum |first=Alberto |coauthors=Claudia Simsolo, Ludmilla Kvasha and Arnon Blum |year=2001 |month=July |title=Toxic Delirium due to Datura Stramonium |journal=Israel Medical Association Journal |volume=3 |issue=7 |pages=538–539 | pmid = 11791426 |url=http://www.ima.org.il/imaj/ar01jul-16.pdf |format=PDF |accessdate=2006-10-17}}</ref> (Datura, angel's trumpet, thorn apple)
**[[Atropa belladonna|Belladonna]] (deadly nightshade)
**[[Salvia divinorum]]<ref name=Przekop>{{Cite journal |doi=10.1176/appi.ajp.2009.08121759 |last=Przekop |first=Peter |coauthors=Timothy Lee|year=2009 |month=July |title=Persistent Psychosis Associated With ''Salvia Divinorum'' Use |pages=832 |journal=American Journal of Psychiatry|volume=166 |issue=832|url=http://ajp.psychiatryonline.org/cgi/content/full/166/7/832 |accessdate=2010-05-14 |pmid=19570943 |unused_data=online}}</ref>

*Volatile solvents and gases (inhalants)
**[[Toluene]],<ref name=Tarsh>{{Cite journal|last=Tarsh |first=M.J. |year=1979 |title=Schizophreniform Psychosis caused by Sniffing Toluene|journal=Journal of the Society for Occupational Medicine |volume=1979 |issue=29 |pages=131–133 |url=http://occmed.oxfordjournals.org/cgi/reprint/29/4/131.pdf |format=PDF |accessdate=2010-05-14}}</ref><ref name=Rao>{{Cite journal|doi=10.4103/0019-5545.58307 |last=Rao |first=Naren P. |coauthors=Arun Gupta, K. Sreejayan, Prabhat K. Chand, Vivek Benegal, and Pratima Murthy |year=2009 |title=Toluene associated schizophrenia-like psychosis|journal=Indian Journal of Psychiatry|volume=51 |issue=4 |pages=329–330 | pmid = 20048466 |pmc=2802388}}</ref> found in glue, paint, thinner, etc. See also [[toluene toxicity]].
**[[Butane]]<ref name=Jung>{{Cite journal|author=Jung IK, Lee HJ, Cho BH |title=Persistent psychotic disorder in an adolescent with a past history of butane gas dependence |journal=European Psychiatry |volume=19 |issue=8 |pages=519–20 |year=2004 |month=December |pmid=15589716 |doi=10.1016/j.eurpsy.2004.09.010}}</ref>
**[[Gasoline]] (petrol),<ref name=Hernandez>{{Cite journal|last=Hernandez-Avila |first=Carlos A. |coauthors=Hector A. Ortega-Soto, Antonio Jasso, Cecilia A. Hasfura-Buenaga, and Henry R. Kranzler |year=1998 |title=Treatment of Inhalant-Induced Psychotic Disorder With Carbamazepine Versus Haloperidol|journal=Psychiatric Services|volume=49 |issue=6 |pages=812–815 |url=http://ps.psychiatryonline.org/cgi/content/full/49/6/812#R34961161 |accessdate=2010-05-28 |pmid=9634163}}</ref>

==References==
{{Reflist|2}}

{{Psychoactive substance use}}

{{DEFAULTSORT:Substance-Induced Psychosis}}
[[Category:Psychosis| ]]
[[Category:Psychiatric diagnosis]]